Novel high performance support materials for oligonucleotide synthesis

We want to contribute to a solution to the pandemic and other diseases. We want to assess a new product area for Redstone Separations for this important and growing gene therapy industry. It is our target to break into the promising solid phase oligonucleotide support material market. For the gene therapy industry and for society, the benefit will be more effective tools to produce flu vaccines, cancer vaccines, antisense drugs, novel therapeutics and personalized medicine.